Direct Answer
Philip Morris International (PM) is the world's largest international tobacco company, selling Marlboro and other cigarette brands in markets outside the United States. Spun off from Altria in 2008, PMI is executing a multi-year transition toward smoke-free products: IQOS heated tobacco (which heats tobacco without burning it) and ZYN nicotine pouches (acquired via Swedish Match in 2022). PMI's goal is to derive the majority of revenue from reduced-risk products, positioning cigarettes as the declining legacy business and smoke-free products as the growth engine.
Philip Morris International (PM) Business & Investor Dossier
Company Snapshot
| Ticker | PM (NYSE) |
|---|---|
| Spun off from Altria | 2008 |
| Headquarters | Stamford, Connecticut (operations internationally) |
| Sector | Consumer Staples |
| Industry | Tobacco |
| Business | International cigarettes (Marlboro) and smoke-free products (IQOS heated tobacco, ZYN nicotine pouches) |
| Notable | IQOS is the world's leading heated tobacco product; 2022 Swedish Match acquisition for ZYN; stated goal of smoke-free product majority revenue; no US cigarette business (that's Altria) |
| Key Competitors | British American Tobacco, Japan Tobacco International, Imperial Brands, Altria (US only) |
What Does Philip Morris International Do?
PMI sells cigarettes in over 180 markets outside the US and is increasingly selling smoke-free alternatives. IQOS heats compressed tobacco sticks to release nicotine-containing vapor without combustion. ZYN nicotine pouches are tobacco-leaf-free oral nicotine products. Both are positioned as reduced-harm alternatives to cigarettes. PMI's long-term strategy is to grow smoke-free products fast enough to more than offset declining cigarette volumes.
Frequently Asked Questions
What does Philip Morris International do and how does it make money?
Philip Morris International (PMI) manufactures and sells tobacco and nicotine products in markets outside the United States (the US rights to Marlboro are owned by Altria, which spun off PMI in 2008). PMI's combustible cigarette portfolio is led by Marlboro and other brands across price tiers. Increasingly, PMI's strategic focus and growth is in reduced-risk products (RRPs): IQOS is a heated tobacco device that heats tobacco sticks (sold as HEETS or Terea) without burning them, generating a tobacco-containing vapor rather than combustion smoke. In 2022, PMI acquired Swedish Match, which owns ZYN, the leading nicotine pouch brand in the US. PMI earns revenue from both device sales (IQOS devices) and consumable sales (HEETS/Terea tobacco sticks and ZYN pouches), with consumables generating the recurring revenue.
How is the IQOS heated tobacco business different from cigarettes and e-cigarettes?
IQOS is a heated tobacco product (HTP), distinct from both traditional cigarettes and e-cigarettes. In combustible cigarettes, tobacco burns at around 600-900 degrees Celsius, producing tar, carbon monoxide, and many thousands of combustion byproducts. E-cigarettes heat a liquid (containing nicotine, propylene glycol, and flavorings) without any tobacco. IQOS heats real tobacco sticks to around 350 degrees Celsius -- above the temperature needed to release nicotine and tobacco flavor, but below the temperature of combustion. PMI's scientific studies and some regulatory bodies have concluded that IQOS produces significantly fewer harmful chemicals than cigarette smoke, though it is not risk-free. The US FDA authorized IQOS as a Modified Risk Tobacco Product (MRTP), allowing PMI to market IQOS with certain reduced-exposure claims in the US market.
Why did Philip Morris International acquire Swedish Match?
PMI acquired Swedish Match in 2022 for approximately $16 billion primarily to obtain ownership of ZYN, the dominant brand in the US nicotine pouch market. Nicotine pouches (small white pouches placed under the lip that deliver nicotine without tobacco leaf) are a rapidly growing smoke-free nicotine category. ZYN had captured the majority of the US nicotine pouch market. The acquisition gave PMI a major position in this fast-growing segment, diversified PMI's smoke-free portfolio beyond heated tobacco into oral nicotine, and provided a significant US distribution and consumer relationship. Swedish Match also had other products including snus (traditional Swedish oral tobacco) with strong Nordic market positions and some cigar operations. The acquisition was a major step in PMI's stated goal of transitioning away from cigarettes.
How is PMI different from Altria and what is the relationship between them?
PMI and Altria were one company (Philip Morris Companies) until 2008, when Altria spun off PMI as a separate company. After the split, Altria retained rights to Marlboro and other brands in the United States, while PMI got rights to the same brands in all other countries. They are now completely separate, publicly traded companies -- they share some brand names internationally vs. domestically, but they are not parent-subsidiary and do not consolidate each other's results. One consequence: IQOS was initially developed by PMI but sold in the US by Altria under a license agreement. That agreement ended, and PMI now sells IQOS in the US directly. PMI also has a stated interest in potentially reuniting with Altria, but such a merger has been discussed and abandoned multiple times.
What are the main risks for Philip Morris International?
Key risks include secular cigarette volume decline (global cigarette consumption is declining over time as smoking rates fall in most markets, which is PMI's largest revenue source), regulatory risk (governments can restrict tobacco and nicotine product sales, marketing, flavors, and nicotine levels; heated tobacco products face evolving regulatory treatment across jurisdictions), currency risk (PMI earns revenue across many currencies; a strong US dollar reduces reported revenue and earnings), transition execution risk (PMI is betting heavily on smoke-free products succeeding commercially and regulatorily; if IQOS adoption stalls or regulators restrict it further, PMI's growth thesis fails), and litigation risk (tobacco litigation remains a background risk, though PMI operates outside the US where historical tobacco litigation has generally been less severe than in the US).